Nalaganje...

Extended interval dosing of natalizumab: a two-center, 7-year experience

BACKGROUND: The enthusiasm for natalizumab, a highly efficacious agent in the treatment of multiple sclerosis (MS), has been tempered by the risks of progressive multifocal leukoencephalopathy associated with its use, and strategies to minimize those risks are of great interest. Extended interval do...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Bomprezzi, Roberto, Pawate, Siddharama
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2014
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4206618/
https://ncbi.nlm.nih.gov/pubmed/25342976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285614540224
Oznake: Označite
Brez oznak, prvi označite!